vs
Side-by-side financial comparison of FONAR CORP (FONR) and Idaho Strategic Resources, Inc. (IDR). Click either name above to swap in a different company.
FONAR CORP is the larger business by last-quarter revenue ($25.5M vs $14.6M, roughly 1.8× Idaho Strategic Resources, Inc.). Idaho Strategic Resources, Inc. runs the higher net margin — 64.3% vs 8.0%, a 56.2% gap on every dollar of revenue. On growth, Idaho Strategic Resources, Inc. posted the faster year-over-year revenue change (92.0% vs 2.4%). Idaho Strategic Resources, Inc. produced more free cash flow last quarter ($8.2M vs $-227.0K). Over the past eight quarters, Idaho Strategic Resources, Inc.'s revenue compounded faster (57.2% CAGR vs -0.3%).
FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.
Idaho Strategic Resources, Inc.IDREarnings & Financial Report
Idaho Strategic Resources, Inc. is a U.S.-based natural resource company focused on the exploration, development, and production of critical and strategic minerals. Primarily operating in Idaho, it targets rare earth elements, gold, silver, and other high-demand minerals, supplying products to the clean energy, defense, and industrial manufacturing sectors across North America.
FONR vs IDR — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.5M | $14.6M |
| Net Profit | $2.1M | $9.4M |
| Gross Margin | — | 68.5% |
| Operating Margin | 13.5% | 62.4% |
| Net Margin | 8.0% | 64.3% |
| Revenue YoY | 2.4% | 92.0% |
| Net Profit YoY | 4.7% | 220.6% |
| EPS (diluted) | — | $0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.5M | $14.6M | ||
| Q3 25 | $26.0M | $11.1M | ||
| Q2 25 | $27.3M | $9.5M | ||
| Q1 25 | $27.2M | $7.3M | ||
| Q4 24 | $24.9M | $7.6M | ||
| Q3 24 | $25.0M | $6.2M | ||
| Q2 24 | $25.9M | $6.1M | ||
| Q1 24 | $25.7M | $5.9M |
| Q4 25 | $2.1M | $9.4M | ||
| Q3 25 | $2.3M | $3.0M | ||
| Q2 25 | $729.3K | $2.8M | ||
| Q1 25 | $2.5M | $1.6M | ||
| Q4 24 | $2.0M | $2.9M | ||
| Q3 24 | $3.1M | $1.6M | ||
| Q2 24 | $830.4K | $2.2M | ||
| Q1 24 | $1.9M | $2.2M |
| Q4 25 | — | 68.5% | ||
| Q3 25 | — | 63.6% | ||
| Q2 25 | — | 57.8% | ||
| Q1 25 | — | 50.8% | ||
| Q4 24 | — | 53.3% | ||
| Q3 24 | — | 48.7% | ||
| Q2 24 | — | 50.2% | ||
| Q1 24 | — | 48.1% |
| Q4 25 | 13.5% | 62.4% | ||
| Q3 25 | 14.1% | 23.4% | ||
| Q2 25 | 5.3% | 26.6% | ||
| Q1 25 | 15.2% | 19.3% | ||
| Q4 24 | 11.9% | 36.2% | ||
| Q3 24 | 21.0% | 23.4% | ||
| Q2 24 | 7.4% | 34.2% | ||
| Q1 24 | 16.8% | 36.3% |
| Q4 25 | 8.0% | 64.3% | ||
| Q3 25 | 8.7% | 26.8% | ||
| Q2 25 | 2.7% | 29.2% | ||
| Q1 25 | 9.2% | 22.1% | ||
| Q4 24 | 7.9% | 38.5% | ||
| Q3 24 | 12.6% | 25.8% | ||
| Q2 24 | 3.2% | 35.2% | ||
| Q1 24 | 7.3% | 36.8% |
| Q4 25 | — | $0.62 | ||
| Q3 25 | — | $0.20 | ||
| Q2 25 | — | $0.20 | ||
| Q1 25 | — | $0.12 | ||
| Q4 24 | — | $0.21 | ||
| Q3 24 | — | $0.12 | ||
| Q2 24 | — | $0.17 | ||
| Q1 24 | — | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $121.0K | — |
| Total DebtLower is stronger | — | $2.3M |
| Stockholders' EquityBook value | $176.9M | $108.2M |
| Total Assets | $217.2M | $116.2M |
| Debt / EquityLower = less leverage | — | 0.02× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $121.0K | — | ||
| Q3 25 | $122.0K | — | ||
| Q2 25 | $56.5M | — | ||
| Q1 25 | $123.0K | — | ||
| Q4 24 | $121.0K | — | ||
| Q3 24 | $136.0K | — | ||
| Q2 24 | $56.5M | $6.3M | ||
| Q1 24 | $134.0K | $5.3M |
| Q4 25 | — | $2.3M | ||
| Q3 25 | — | $3.0M | ||
| Q2 25 | — | $3.3M | ||
| Q1 25 | — | $3.7M | ||
| Q4 24 | — | $1.7M | ||
| Q3 24 | — | $2.9M | ||
| Q2 24 | $66.9K | $2.7M | ||
| Q1 24 | — | $3.3M |
| Q4 25 | $176.9M | $108.2M | ||
| Q3 25 | $174.9M | $74.3M | ||
| Q2 25 | $172.6M | $49.3M | ||
| Q1 25 | $171.9M | $39.8M | ||
| Q4 24 | $169.8M | $37.7M | ||
| Q3 24 | $168.7M | $33.1M | ||
| Q2 24 | $166.0M | $25.4M | ||
| Q1 24 | $165.8M | $21.6M |
| Q4 25 | $217.2M | $116.2M | ||
| Q3 25 | $218.4M | $83.1M | ||
| Q2 25 | $216.9M | $57.7M | ||
| Q1 25 | $214.9M | $48.1M | ||
| Q4 24 | $208.0M | $44.0M | ||
| Q3 24 | $212.3M | $40.8M | ||
| Q2 24 | $214.2M | $32.2M | ||
| Q1 24 | $209.6M | $28.7M |
| Q4 25 | — | 0.02× | ||
| Q3 25 | — | 0.04× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | — | 0.09× | ||
| Q2 24 | 0.00× | 0.11× | ||
| Q1 24 | — | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $171.0K | $10.7M |
| Free Cash FlowOCF − Capex | $-227.0K | $8.2M |
| FCF MarginFCF / Revenue | -0.9% | 56.0% |
| Capex IntensityCapex / Revenue | 1.6% | 17.7% |
| Cash ConversionOCF / Net Profit | 0.08× | 1.15× |
| TTM Free Cash FlowTrailing 4 quarters | $5.7M | $12.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $171.0K | $10.7M | ||
| Q3 25 | $1.7M | $2.4M | ||
| Q2 25 | $4.2M | $3.5M | ||
| Q1 25 | $3.1M | $2.4M | ||
| Q4 24 | $2.2M | $3.2M | ||
| Q3 24 | $1.7M | $2.5M | ||
| Q2 24 | $4.6M | $2.6M | ||
| Q1 24 | $2.8M | $2.6M |
| Q4 25 | $-227.0K | $8.2M | ||
| Q3 25 | $-177.0K | $709.8K | ||
| Q2 25 | $3.6M | $2.5M | ||
| Q1 25 | $2.6M | $1.0M | ||
| Q4 24 | $1.5M | $2.1M | ||
| Q3 24 | $-148.0K | $1.9M | ||
| Q2 24 | $4.2M | $2.4M | ||
| Q1 24 | $2.6M | $2.3M |
| Q4 25 | -0.9% | 56.0% | ||
| Q3 25 | -0.7% | 6.4% | ||
| Q2 25 | 13.1% | 26.5% | ||
| Q1 25 | 9.4% | 13.8% | ||
| Q4 24 | 6.0% | 28.0% | ||
| Q3 24 | -0.6% | 30.4% | ||
| Q2 24 | 16.1% | 38.7% | ||
| Q1 24 | 10.2% | 38.3% |
| Q4 25 | 1.6% | 17.7% | ||
| Q3 25 | 7.2% | 15.3% | ||
| Q2 25 | 2.4% | 10.8% | ||
| Q1 25 | 2.2% | 19.4% | ||
| Q4 24 | 3.0% | 13.6% | ||
| Q3 24 | 7.2% | 9.8% | ||
| Q2 24 | 1.6% | 4.3% | ||
| Q1 24 | 0.7% | 5.5% |
| Q4 25 | 0.08× | 1.15× | ||
| Q3 25 | 0.75× | 0.81× | ||
| Q2 25 | 5.79× | 1.28× | ||
| Q1 25 | 1.26× | 1.50× | ||
| Q4 24 | 1.14× | 1.08× | ||
| Q3 24 | 0.53× | 1.56× | ||
| Q2 24 | 5.54× | 1.22× | ||
| Q1 24 | 1.50× | 1.19× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
IDR
Segment breakdown not available.
